BTB Korea Co Ltd

BTB Korea Co Ltd has a liquidity position that is characterized by a current ratio of 1.86, indicating that the company has 1.86 times more current assets than current liabilities. The company's cash and equivalents amount to 6,790,929,210 KRW, which is a significant portion of its total assets of 44,860,783,720 KRW. However, the company's operating cash flow is negative at -330,986,070 KRW, which may indicate challenges in generating cash from its core operations.

In terms of profitability, BTB Korea Co Ltd has a return on equity (ROE) of 0.0126 and a return on assets (ROA) of 0.0073. These figures suggest that the company is generating relatively low returns on its equity and assets compared to industry benchmarks. The company's net income of 328,083,670 KRW is derived from a revenue of 6,193,928,290 KRW, with a gross profit of 1,578,743,250 KRW. The operating income of 281,418,240 KRW indicates that the company is able to cover its operating expenses, but the low ROE and ROA suggest that the company's profitability is not translating into strong returns for shareholders.

The company's revenue is not segmented by geographic regions or product lines in the provided data, making it difficult to assess the geographic exposure or the concentration of revenue in specific segments. However, the company's total liabilities of 18,738,350,050 KRW and total equity of 26,122,433,670 KRW indicate a debt-to-equity ratio of 0.44, which is relatively low and suggests a conservative capital structure.

Looking at the growth trajectory, the company's revenue of 6,193,928,290 KRW and net income of 328,083,670 KRW indicate a stable but not rapidly growing business. The company's capital expenditure of -9,163,800 KRW suggests that it is not investing heavily in new assets, which may limit its future growth potential. The company's free cash flow of 411,080,870 KRW indicates that it has some flexibility to invest in growth opportunities or return value to shareholders.

The risk assessment for BTB Korea Co Ltd indicates a medium liquidity risk and a low dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which may indicate potential liquidity constraints. The company's shares outstanding are the same for both basic and diluted shares, suggesting that there is no significant dilution potential from stock options or convertible securities. The company's recent financial performance, including a negative operating cash flow, may also pose a risk to its financial stability.

Recent events and filings for BTB Korea Co Ltd include an analyst estimate of last actual EPS at -10,128.00 KRW, which indicates a loss per share. This negative EPS may be a concern for investors and could affect the company's stock price. The company's financial performance and risk factors should be closely monitored to assess its future prospects and potential for growth.

Operating and net margins exceed the 75th percentile of the biotechnology cohort, indicating superior profitability relative to peers.

Return on equity and return on assets rank in the top quartile compared to the biotechnology cohort median.

Revenue increased by 123.3% year-over-year in the latest period, demonstrating significant top-line growth momentum.

Net income improved by 59.6% year-over-year, signaling a strong recovery in bottom-line profitability from prior losses.

Capital expenditure relative to revenue is significantly lower than the cohort median, suggesting efficient capital deployment.

The company carries a high credit risk flag, indicating potential difficulties in meeting financial obligations or servicing debt.

Debt-to-equity ratio is in the bottom quartile of the cohort, reflecting significantly higher leverage than most peers.

Cash conversion is in the bottom quartile of the cohort, highlighting poor ability to convert earnings into cash.

Free cash flow remains negative at -3.66 billion KRW, indicating ongoing cash burn despite revenue growth.

Long-term debt increased substantially to 13.2 billion KRW, raising concerns about financial flexibility and solvency.

Revenue KRW 10.04B; Operating income KRW 864.7M.

• ▍Revenue KRW 10.04B
• ▍Operating income KRW 864.7M
• ▍Net margin 6.9%

Revenue KRW 7.12B; Operating income -KRW 76.5M.

• ▍Revenue KRW 7.12B
• ▍Operating income -KRW 76.5M
• ▍Net margin -1.4%

Revenue KRW 6.78B; Operating income -KRW 329.0M.

• ▍Revenue KRW 6.78B
• ▍Operating income -KRW 329.0M
• ▍Net margin -16.0%

Revenue KRW 6.19B; Operating income KRW 281.4M.

• ▍Revenue KRW 6.19B
• ▍Operating income KRW 281.4M
• ▍Net margin 5.3%

Revenue KRW 30.14B, −4,1% YoY; Operating income −44,8% YoY.

• ▍Revenue KRW 30.14B, −4,1% YoY
• ▍Operating income −44,8% YoY
• ▍Net income −109,6% YoY
• ▍Free cash flow −113,3% YoY
• ▍Net margin -0.5%

Revenue KRW 31.44B; Operating income KRW 1.34B.

• ▍Revenue KRW 31.44B
• ▍Operating income KRW 1.34B
• ▍Net margin 5.3%